Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.60%
-1.02%
+7.50%
+0.72%
LLY
Eli Lilly and Company
$787.82
Chart
$722.57 (+9.03%)
$757.18 (+4.05%)
$911.06 (-13.53%)
$804.62 (-2.09%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.60%
-1.02%
+7.50%
+0.72%
LLY
Eli Lilly and Company
Current Price
$787.82
Strong Buy
Login to view Eli Lilly and Company (LLY) recommendation from the last 90 days from financial news and social media.
Chart
$722.57 (+9.03%)
$757.18 (+4.05%)
$911.06 (-13.53%)
$804.62 (-2.09%)
LLY Latest Analysis
This Is What Whales Are Betting On Eli Lilly. Deep-pocketed investors have adopted a ish approach towards Eli Lilly (NYSE:) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in LLY usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga'.s options scanner
Thu Jul 10, 2025
Zepbound Powers Eli Lillys Upbeat Q2 Outlook. ) is set to release its second-quarter earnings on August 7. According to dataanalysts are anticipating adjusted earnings of $5.56 per share and sales of $14.4 billion.Expectations are slightly higher for the quarter primarily driven by the strong performance of its obesity drug Zepbound. The pharmaceutical giant a dominant player in the incretin/GLP-1 drug market for obesity and diabetes continues to draw investor attention with its robust pipeline
Wed Jul 9, 2025
FDA Approves New Dosing Schedule For Eli Lillys Kisunla In Alzheimers Treatment. ) Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’.s disease (AD)..In the the modified titration schedule significantly reduced the incidence of amyloid-related imaging abnormalities with edema/effusion (ARIA-E) compared to the original dosing schedule at 24 and 52 weeks while still achieving similar levels of amyloid plaque removal .The new recommend
Wed Jul 9, 2025
Eli Lilly granted FDA label update for Alzheimers drug Kisunla.
Wed Jul 9, 2025
Noteworthy Thursday Option Activity: LLY EQIX MGM. Among the underlying components of the S&.P 500 index we saw noteworthy options trading volume today in Eli Lilly (Symbol: LLY) where a total of 18927 contracts have traded so far representing approximately 1.9 million underlying shares. That amounts to about 57.4% of LL
Thu Jun 26, 2025
3 Reasons to Buy Eli Lilly Stock Like Theres No Tomorrow. Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and delivered strong market performance -- so strong that detractors might think its too late to invest. Lillys forward price-to-earnings (P/E) ratio currentl
Wed Jun 25, 2025
Novos India Move Could Reshape The Weight-Loss Drug War With Eli Lilly. ) has reportedly drug Wegovy (semaglutide) in India to compete with ).In March this year United States pharma giant Eli Lilly launched its popular weight loss drug Mounjaro (tirzepatide) in India. It is expected to have the second-largest population of overweight or .A Reuters report on Tuesday said that Wegovy a weekly injection will be available in pharmacies by the end of this month. It could take some market share away
Tue Jun 24, 2025
New AI Rollouts Signal Shift From Hype to Healthcare Reality. News CommentaryIssued on behalf of Avant Technologies Inc. as the new tech is proving it can improve diagnostic accuracies drug discoveries and administration work flow. Healthcare leaders are already reporting benefits including through voice-based AI tools and the use of AI agents to support smarter care delivery. Behind the scenes the tech is being developed by innovators who have been making serious progress for AI in healthcar
Tue Jun 24, 2025
Novo Nordisk rolls out weight loss drug Wegovy in India following Eli Lillys Mounjaro launch.
Tue Jun 24, 2025
Eli Lilly stock maintains Overweight rating at Morgan Stanley on muscle data.
Mon Jun 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings